ANPC AnPac Bio-Medical Science Co., Ltd. Stock Quote

ANPC [NASD]

Index	-	P/E	-	EPS (ttm)	-1.42	Insider Own	21.24%	Shs Outstand	15.40M	Perf Week	-36.36%
Market Cap	13.90M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	0.00%	Shs Float	5.18M	Perf Month	-32.85%
Income	-18.40M	PEG	-	EPS next Q	-	Inst Own	1.40%	Short Float	1.10%	Perf Quarter	-73.66%
Sales	2.50M	P/S	5.56	EPS this Y	17.90%	Inst Trans	-	Short Ratio	0.16	Perf Half Y	-81.61%
Book/sh	0.00	P/B	-	EPS next Y	-	ROA	-183.60%	Target Price	-	Perf Year	-87.04%
Cash/sh	0.05	P/C	15.44	EPS next 5Y	-	ROE	-	52W Range	0.73 - 12.09	Perf YTD	-41.06%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-827.70%	52W High	-94.05%	Beta	-
Dividend %	-	Quick Ratio	0.30	Sales past 5Y	-	Gross Margin	59.30%	52W Low	-1.70%	ATR	0.13
Employees	86	Current Ratio	0.30	Sales Q/Q	7.30%	Oper. Margin	-	RSI (14)	25.66	Volatility	23.83% 12.51%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	61.20%	Profit Margin	-	Rel Volume	0.62	Prev Close	0.84
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	347.69K	Price	0.72
Recom	2.00	SMA20	-36.04%	SMA50	-44.16%	SMA200	-77.63%	Volume	212,592	Change	-14.35%

Jan-25-22 07:30AM	Leading US Market Analysis and Research Firm Ranked AnPac Bio Globally Number One in Multi-Cancer Screening and Detection Test Volume GlobeNewswire +6.35%
Jan-24-22 05:00PM	AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency GlobeNewswire -23.08%
Jan-04-22 07:30AM	AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022 GlobeNewswire
Dec-10-21 07:30AM	Technical Paper on AnPac Bio Novel CDA Cancer Detection Technology Published by Peer-Reviewed International Medical Journal GlobeNewswire -7.75%
Dec-06-21 07:18AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday InvestorPlace -6.52%
Nov-26-21 01:30PM	AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8% GlobeNewswire
Nov-11-21 03:19AM	CORRECTION -- Anpac Bio, USA GlobeNewswire
Nov-09-21 11:55PM	AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares GlobeNewswire
05:21PM	UPDATE - AnPac Bio Commences Proposed Public Offering of American Depositary Shares GlobeNewswire
04:59PM	AnPac Bio Commences Proposed Public Offering of American Depositary Shares GlobeNewswire
Nov-08-21 07:30AM	Anpac Bio Invites You to Join Us at the Q4 Virtual Investor Summit Newsfile
Oct-22-21 12:43PM	AnPac Bio-Medical Science Co. Ltd.'s Unique Platform Offering Comprehensive Blood Test Data, New Approach to Disease Screening Benzinga
Oct-13-21 10:53AM	AnPac Bio-Medical Science Co. Ltd. Among Leading Biotech Companies Innovating the Field of Early Cancer Screening and Detection Benzinga
Oct-04-21 02:47PM	AnPac Bio-Medical Science Co. Ltd. Announces Study Results Confirming Correlation Between CDA Score, Risk of Cancer Benzinga
07:30AM	AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases GlobeNewswire
Oct-01-21 12:42PM	AnPac Bio-Medical Science Co. Ltd. First Half Revenue Numbers Up by 128.5%, Non-GAAP Loss Down by 18.3% Benzinga -7.41%
07:30AM	AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3% GlobeNewswire
Sep-30-21 04:05PM	AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency GlobeNewswire
Sep-22-21 10:57AM	AnPac Bio-Medical Science Co. Ltd. Receives College Of American Pathologists Accreditation For US Laboratory Benzinga +11.24%
Sep-07-21 12:19PM	BioMedNewsBreaks AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase In Subsidiary Holding Benzinga
Sep-03-21 04:15PM	AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60% GlobeNewswire
Aug-30-21 07:30AM	AnPac Bios USA Laboratory Receives Accreditation from the College of American Pathologists GlobeNewswire
Aug-23-21 07:30AM	AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device GlobeNewswire
Aug-17-21 07:30AM	AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO GlobeNewswire
Aug-05-21 07:30AM	AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions GlobeNewswire
Jul-23-21 07:30AM	AnPac Bio Announces Appointment of New Independent Director GlobeNewswire -8.15%
Jul-21-21 06:30AM	AnPac Bio Began Generating Contract Medical Device R&D Revenue GlobeNewswire +6.28%
Jul-20-21 06:30AM	AnPac Bio Pre-announces that During First Half 2021, Total Commercial Testing Volume Increased Approximately 110% Over the Same Period 2020 and Q2 Paid Cancer Tests Increased Approximately 270% Over Q1 GlobeNewswire
Jun-18-21 09:22AM	AnPac Bio-Medical Stock Moves Higher On First Disease Treatment US Patent Benzinga +5.77%
06:30AM	AnPac Bios First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds GlobeNewswire
Jun-09-21 01:37AM	Would Shareholders Who Purchased AnPac Bio-Medical Science's (NASDAQ:ANPC) Stock Year Be Happy With The Share price Today? Simply Wall St.
May-27-21 06:30AM	AnPac Bio Reports Strong First Quarter in 2021, with 137.2% Increase in Revenue and Record Number of Commercial Tests Completed GlobeNewswire -5.12%
May-25-21 08:15AM	AnPac Bio Shares Jump on Cancer Treatment Technology Related Joint Venture Benzinga
06:30AM	AnPac Bio Launches Novel Cancer Treatment Technology and Product Joint Venture - Utilizing Findings from 10 Years of Early-Stage Cancer Detection Work Involving over 222,200 Sample Database GlobeNewswire
May-17-21 07:49AM	ANPC: 2020 Financial & Operational Results Zacks Small Cap Research
Apr-30-21 04:45PM	AnPac Bio Announces Filing of Annual Report on Form 20-F for 2020 GlobeNewswire +5.12%
08:00AM	AnPac Bio Reports Fiscal Year 2020 Annual Financial Results (89.1% Increase in Revenue and 20.7% Decrease in Net Loss) GlobeNewswire
Apr-27-21 05:03PM	AnPac Bio to Report Fiscal Year 2020 Financial Results on Friday, April 30, 2021 GlobeNewswire
Apr-16-21 04:15PM	AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020 GlobeNewswire -10.71%
Mar-10-21 07:25AM	The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link Benzinga -22.18%
Mar-09-21 07:30AM	AnPac Bio Developed and Completed Evaluations of New Generation Cancer Detection Sensor with Improved Performance GlobeNewswire +48.45%
Mar-05-21 04:35PM	AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement GlobeNewswire
Feb-16-21 04:38AM	ANPC: Class III Registration Testing Approved Zacks Small Cap Research +5.79%
Feb-08-21 07:00AM	Chinas NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility) GlobeNewswire
Feb-01-21 07:30AM	AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection GlobeNewswire
Dec-15-20 07:45AM	ANPC: Updated Guidance Prompts Target Increase Zacks Small Cap Research +7.37%
Dec-14-20 07:30AM	AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases GlobeNewswire +35.07%
Dec-10-20 11:01PM	News Flash: Analysts Just Made An Incredible Upgrade To Their AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Forecasts Simply Wall St.
Dec-04-20 04:01PM	Anpac Bio Announces Change of Auditor GlobeNewswire -7.59%
Nov-25-20 11:01AM	Why These 3 Health Care Stocks Are Trading Higher Today Benzinga +104.00%
07:30AM	AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020 GlobeNewswire
Nov-16-20 04:01PM	Anpac Bio Announces Appointment of New Independent Director GlobeNewswire
Nov-10-20 07:30AM	AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing GlobeNewswire
Nov-02-20 07:30AM	AnPac Bios Investee Company in China Received COVID-19 Nucleic Acid Test Certification and Began Volume Tests and Collaborations with AnPac Bio GlobeNewswire +22.21%
03:30AM	ANPC: Next Gen Cancer Screening Zacks Small Cap Research
Oct-26-20 06:45AM	Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer GlobeNewswire
Oct-13-20 05:00AM	ANPC: AnPac Cancer Differentiation Analysis (CDA) Technology Zacks Small Cap Research
Oct-07-20 07:00AM	AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements GlobeNewswire
Oct-01-20 07:30AM	AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million GlobeNewswire
Sep-23-20 08:15AM	Tiger Asia Intelligence reiterates a Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC) PR Newswire
Sep-15-20 07:00AM	AnPac Bio Receives Major Immunology Testing Contract GlobeNewswire
Sep-11-20 08:05AM	The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review Benzinga
Sep-10-20 06:53AM	AnPac Bio Reports First Six Months of 2020 Financial Results GlobeNewswire -8.75%
Sep-08-20 10:04AM	Company News for Sep 8, 2020 Zacks -8.93%
Sep-04-20 07:30AM	AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study GlobeNewswire +7.23%
Aug-28-20 08:00AM	AnPac Bio to Report its First Six Months 2020 Financial Results on Thursday, September 10, 2020 GlobeNewswire -5.22%
Aug-24-20 07:30AM	AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification GlobeNewswire
Aug-11-20 07:30AM	AnPac Bio Opens US Philadelphia Lab Operations GlobeNewswire -7.88%
Aug-07-20 07:30AM	AnPac Bio Validating Approved COVID-19 Antibody Test GlobeNewswire +38.43%
Aug-04-20 07:30AM	AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness GlobeNewswire
Jul-29-20 08:26AM	AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests GlobeNewswire +28.21%
Jul-13-20 08:40AM	AnPac Bio Completed 1st Half Year with Increased ASP and Revenue GlobeNewswire
Jun-26-20 08:00AM	AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening GlobeNewswire
Jun-22-20 08:46AM	AnPac Bio Launches New Immunology Test Product Line GlobeNewswire -5.72%
Jun-19-20 08:46AM	AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening GlobeNewswire +8.87%
Jun-10-20 04:20PM	Tiger Asia Intelligence reiterate Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC) PR Newswire
Jun-03-20 07:39AM	The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study Benzinga
Jun-02-20 05:00PM	AnPac Bio Announces Appointment of New Chief Financial Officer GlobeNewswire
May-26-20 08:00AM	AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States GlobeNewswire
May-18-20 08:30AM	AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019 GlobeNewswire
08:24AM	AnPac Files Its Annual Report on Form 20-F GlobeNewswire
May-11-20 06:46AM	AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States GlobeNewswire +10.39%
Apr-30-20 09:15AM	ANPC: A Blood Test for Cancer Diagnosis Zacks Small Cap Research
05:00AM	ANPC: A Blood Test for Cancer Diagnosis Zacks Small Cap Research
Mar-30-20 08:30AM	Tiger Asia Intelligence Initiates Coverage on AnPac Bio, Ltd PR Newswire
Mar-27-20 08:00AM	AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists GlobeNewswire
Mar-24-20 07:30AM	AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States PR Newswire +11.53%
Mar-03-20 08:30AM	AnPac Bio-Medical Science Announces Cooperation with Dragon Gate Investment Partners PR Newswire -6.00%
Feb-27-20 09:00AM	AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project PR Newswire
Feb-06-20 08:15AM	AnPac Bio Gains Two New Insurance Customers PR Newswire
Feb-03-20 09:17AM	WestPark Capital announces trading of $16,000,000 IPO for AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) GlobeNewswire
Jan-30-20 02:09PM	Univest Securities, LLC. Announces Trading of IPO for its Client AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), Marking the 1st IPO in 2020 Univest Acts as a Joint Book Running Manager GlobeNewswire
12:47PM	AnPac Bio Announces Pricing of Initial Public Offering PR Newswire

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience